Publicacións en colaboración con investigadores/as de Universidad Autónoma de Madrid (30)

2024

  1. Clinical Characteristics of Patients With Acquired Partial Lipodystrophy: A Multicenter Retrospective Study

    The Journal of clinical endocrinology and metabolism, Vol. 109, Núm. 3, pp. e932-e944

2023

  1. Characterization and Clinical Association of Autoantibodies Against Perilipin 1 in Patients With Acquired Generalized Lipodystrophy

    Diabetes, Vol. 72, Núm. 1, pp. 71-84

2022

  1. MicroRNA-4732-3p Is Dysregulated in Breast Cancer Patients with Cardiotoxicity, and Its Therapeutic Delivery Protects the Heart from Doxorubicin-Induced Oxidative Stress in Rats

    Antioxidants, Vol. 11, Núm. 10

  2. Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial

    BMC Cardiovascular Disorders, Vol. 22, Núm. 1

2021

  1. Complement factor d (Adipsin) levels are elevated in acquired partial lipodystrophy (barraquer–simons syndrome)

    International Journal of Molecular Sciences, Vol. 22, Núm. 12

2020

  1. Correction: Immunological features of patients affected by Barraquer-Simons syndrome (Orphanet Journal of Rare Diseases DOI: 10.1186/s13023-019-1292-1)

    Orphanet Journal of Rare Diseases

  2. Dietary magnesium supplementation improves lifespan in a mouse model of progeria

    EMBO Molecular Medicine, Vol. 12, Núm. 10

  3. Evidence of ongoing complement activation on adipose tissue from an 11-year-old girl with Barraquer–Simons syndrome

    Journal of Dermatology, Vol. 47, Núm. 12, pp. 1439-1444

  4. Immunological features of patients affected by Barraquer-Simons syndrome

    Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1

  5. Redox theory in progeria

    Aging, Vol. 12, Núm. 21, pp. 20934-20935

2019

  1. ATP-based therapy prevents vascular calcification and extends longevity in a mouse model of Hutchinson–Gilford progeria syndrome

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 47, pp. 23698-23704

  2. New treatments for progeria

    Aging

  3. Questioning the safety of calcidiol in hemodialysis patients

    Nutrients, Vol. 11, Núm. 5

2018

  1. Autoantibodies against perilipin 1 as a cause of acquired generalized lipodystrophy

    Frontiers in Immunology, Vol. 9, Núm. SEP

  2. Role of pyrophosphate in vascular calcification in chronic kidney disease

    Nefrologia

2017

  1. A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients

    PLoS ONE, Vol. 12, Núm. 3

  2. Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia

    Journal of Clinical Lipidology, Vol. 11, Núm. 1, pp. 260-271

  3. Differences between 2nd and 3rd generation seric parathormone determination methods on mortality in haemodialysis patients

    Nefrologia, Vol. 37, Núm. 4, pp. 389-396

  4. Phosphate, pyrophosphate, and vascular calcification: A question of balance

    European Heart Journal

  5. Réplica a «Tratamiento de la hiperuricemia asintomática»

    Revista Clinica Espanola